Atsushi Takenaka
Overview
Explore the profile of Atsushi Takenaka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
283
Citations
1661
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yamaguchi N, Morizane S, Yamane H, Shimizu R, Nishikawa R, Kimura Y, et al.
Anticancer Res
. 2025 Mar;
45(3):1215-1224.
PMID: 40037868
Background/aim: Few studies have verified the relationship between treatment outcomes of robot-assisted radical cystectomy (RARC) and laparoscopic radical cystectomy (LRC). This study aimed to compare the perioperative and oncologic outcomes...
2.
Kimura Y, Honda M, Yamane H, Shimizu R, Nishikawa R, Yamaguchi N, et al.
Int J Urol
. 2025 Feb;
PMID: 40012528
Objective: We evaluated the long-term outcomes in health-related quality of life (QOL) after robot-assisted radical prostatectomy (RARP) and the factors influencing them. Methods: Overall, 246 patients who underwent RARP were...
3.
Kitagawa Y, Yoshida K, Takeuchi Y, Tanino T, Sakaguchi H, Shimizu R, et al.
Yonago Acta Med
. 2025 Feb;
68(1):12-21.
PMID: 39968120
Background: To evaluate and compare the survivals and radiotherapy-induced adverse events (AEs) of intensity-modulated radiotherapy (IMRT) with androgen deprivation therapy (ADT) and trimodality therapy, including low-dose iodine-125 brachytherapy, external beam...
4.
Hikita K, Nishikawa R, Taniguchi S, Mae Y, Iyama T, Takata T, et al.
Yonago Acta Med
. 2025 Feb;
68(1):75-78.
PMID: 39968119
The incidence of malignancy following long-term immunosuppression is increased in organ transplant recipients. We report a case of a patient with right ureteral and bladder cancer after living donor kidney...
5.
Zachariou A, Baltogiannis D, Zikopoulos A, Sapouna V, Giannakis I, Kaltsas A, et al.
Cureus
. 2025 Feb;
17(1):e77306.
PMID: 39935935
Female sexual dysfunction (FSD) is prevalent among women with multiple sclerosis (MS), leading to significant impairments in quality of life. Despite various available treatments, current approaches often fail to address...
6.
Morizane S, Hussein A, Jing Z, Yamamoto A, Yamane H, Shimizu R, et al.
J Robot Surg
. 2025 Jan;
19(1):54.
PMID: 39832045
In recent times, innovative surgical robotics have emerged and gained widespread adoption. This study aimed to compare the perioperative outcomes associated with robot-assisted radical prostatectomy (RARP) using three different robotic...
7.
Yamane H, Morizane S, Yamaguchi N, Toji S, Hikita K, Honda M, et al.
Int J Urol
. 2025 Jan;
PMID: 39823187
Objectives: Accurate preoperative staging of upper tract urothelial carcinoma is often difficult. Therefore, we aimed to investigate the preoperative factors associated with pathological upstaging in patients with upper tract urothelial...
8.
Morizane S, Takenaka A
Prostate Int
. 2025 Jan;
12(3):117-127.
PMID: 39816936
Pelvic lymph node dissection (PLND) is important for accurate staging and prognosis of prostate cancer. Several guidelines recommend extended pelvic lymph node dissection (ePLND) for patients with non-low-risk prostate cancer....
9.
Morizane S, Miki J, Shimbo M, Kanno T, Miura N, Yamada Y, et al.
Int J Urol
. 2024 Aug;
31(12):1300-1310.
PMID: 39176984
Pelvic lymph node dissection (PLND) is important for accurate staging and prognosis of prostate and/or bladder cancer. Several guidelines recommend extended PLND for patients with these cancers. However, the therapeutic...
10.
Yasukawa R, Kawamoto B, Muraoka K, Nakamura K, Honda M, Takenaka A
Yonago Acta Med
. 2024 Aug;
67(3):266-269.
PMID: 39176189
Treatment-related neuroendocrine prostate cancer (tNEPC) occurs after androgen deprivation therapy and has a poor prognosis; however, there are few effective treatments for tNEPC. Therefore, tNEPC management is often challenging. This...